Patents by Inventor Frank Stieber

Frank Stieber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11056652
    Abstract: The present invention relates to certain fluorenes, to the use of the compounds in an electronic device, and to an electronic device comprising at least one of these compounds. Furthermore, the present invention relates to a process for the preparation of the compounds and to a formulation and composition comprising one or more of the compounds.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: July 6, 2021
    Assignee: Merck Patent GmbH
    Inventors: Jochen Pfister, Frank Stieber, Elvira Montenegro, Teresa Mujica-Fernaud, Frank Voges
  • Patent number: 10573818
    Abstract: The present invention relates to compounds of formula (1) which are suitable for use in electronic devices, especially in organic electroluminescent devices.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: February 25, 2020
    Assignee: Merck Patent GmbH
    Inventors: Teresa Mujica-Fernaud, Elvira Montenegro, Jochen Pfister, Irina Martynova, Frank Stieber
  • Publication number: 20190341559
    Abstract: The present application relates to a material comprising a monoarylamine of a defined formula and a p-dopant of a defined formula. The present application further relates to the use of said material in an organic layer of an electronic device, the device preferably being an organic electroluminescent device (OLED).
    Type: Application
    Filed: July 22, 2019
    Publication date: November 7, 2019
    Inventors: Frank VOGES, Frank STIEBER, Philipp STOESSEL, Teresa MUJICA-FERNAUD, Christof PFLUMM, Joachim KAISER
  • Publication number: 20190288209
    Abstract: The present invention relates to certain fluorenes, to the use of the compounds in an electronic device, and to an electronic device comprising at least one of these compounds. Furthermore, the present invention relates to a process for the preparation of the compounds and to a formulation and composition comprising one or more of the compounds.
    Type: Application
    Filed: May 30, 2019
    Publication date: September 19, 2019
    Inventors: Jochen PFISTER, Frank STIEBER, Elvira MONTENEGRO, Teresa MUJICA-FERNAUD, Frank VOGES
  • Patent number: 10407394
    Abstract: The invention relates to a heteroaryl compound according to formula (I) and to the use thereof in electronic devices.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: September 10, 2019
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Philipp Stoessel, Thomas Eberle, Anja Jatsch, Jonas Valentin Kroeber, Christof Pflumm, Irina Martynova, Frank Voges, Frank Stieber
  • Patent number: 10396297
    Abstract: The present application relates to a material comprising a monoarylamine of a defined formula and a p-dopant of a defined formula. The present application further relates to the use of said material in an organic layer of an electronic device, the device preferably being an organic electroluminescent device (OLED).
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: August 27, 2019
    Assignee: Merck Patent GmbH
    Inventors: Frank Voges, Frank Stieber, Philipp Stoessel, Teresa Mujica-Fernaud, Christof Pflumm, Joachim Kaiser
  • Patent number: 10355217
    Abstract: The present invention relates to certain fluorenes, to the use of the compounds in an electronic device, and to an electronic device comprising at least one of these compounds. Furthermore, the present invention relates to a process for the preparation of the compounds and to a formulation and composition comprising one or more of the compounds.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: July 16, 2019
    Assignee: Merck Patent GmbH
    Inventors: Jochen Pfister, Frank Stieber, Elvira Montenegro, Teresa Mujica-Fernaud, Frank Voges
  • Patent number: 10224492
    Abstract: The present application relates to spirobifluorene derivatives of a formula (I), to the use thereof in electronic devices, especially in organic electroluminescent devices (OLEDs), where they may be used in hole-transporting function, and to processes for preparing said derivatives. The compounds have one or more properties selected from very good hole-conducting properties, very good electron-blocking properties, high glass transition temperature, high oxidation stability, good solubility and high thermal stability.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: March 5, 2019
    Assignee: Merck Patent GmbH
    Inventors: Jochen Pfister, Frank Stieber, Elvira Montenegro, Teresa Mujica-Fernaud
  • Patent number: 10158083
    Abstract: The present invention relates to compounds of the formula (1), which are suitable for use in electronic devices, in particular in organic electroluminescent devices.
    Type: Grant
    Filed: November 18, 2014
    Date of Patent: December 18, 2018
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Irina Martynova, Elvira Montenegro, Teresa Mujica-Fernaud, Frank Voges, Jonas V. Kroeber, Frank Stieber
  • Publication number: 20180212149
    Abstract: The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
    Type: Application
    Filed: July 1, 2016
    Publication date: July 26, 2018
    Inventors: Jochen PFISTER, Teresa MUJICA-FERNAUD, Elvira MONTENEGRO, Frank STIEBER, Frank VOGES
  • Patent number: 9926319
    Abstract: The invention provides novel substituted pyridyl piperidine compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: March 27, 2018
    Assignees: MERCK PATENT GMBH, Cancer Research Technology Limited
    Inventors: Kai Schiemann, Frank Stieber, Michel Calderini, Julian Blagg, Aurelie Mallinger, Dennis Waalboer, Christian Rink, Simon Ross Crumpler
  • Publication number: 20180006245
    Abstract: The present application relates to spirobifluorene derivatives of a formula (I), to the use thereof in electronic devices, and to processes for preparing said derivatives.
    Type: Application
    Filed: December 8, 2015
    Publication date: January 4, 2018
    Inventors: Jochen PFISTER, Frank STIEBER, Elvira MONTENEGRO, Teresa MUJICA-FERNAUD
  • Patent number: 9834541
    Abstract: The invention provides novel substituted 2-aminopyridine compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: December 5, 2017
    Assignees: CANCER RESEARCH TECHNOLOGY LIMITED, MERCK PATENT GMBH
    Inventors: Kai Schiemann, Frank Stieber, Julian Blagg, Aurelie Mallinger, Dennis Waalboer, Christian Rink, Simon Ross Crumpler
  • Publication number: 20170331053
    Abstract: The present application relates to a material comprising a monoarylamine of a defined formula and a p-dopant of a defined formula. The present application further relates to the use of said material in an organic layer of an electronic device, the device preferably being an organic electroluminescent device (OLED).
    Type: Application
    Filed: September 25, 2015
    Publication date: November 16, 2017
    Inventors: Frank VOGES, Frank STIEBER, Philipp STOESSEL, Teresa MUJICA-FERNAUD, Christof PFLUMM, Joachim KAISER
  • Publication number: 20170317283
    Abstract: The present invention relates to compounds of formula (1) which are suitable for use in electronic devices, especially in organic electroluminescent devices.
    Type: Application
    Filed: November 5, 2015
    Publication date: November 2, 2017
    Inventors: Teresa MUJICA-FERNAUD, Elvira MONTENEGRO, Jochen PFISTER, Irina MARTYNOVA, Frank STIEBER
  • Publication number: 20170107222
    Abstract: The invention provides novel substituted pyridyl piperidine compounds according to Formula (I) which are Wnt pathway inhibitors, their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Application
    Filed: March 10, 2015
    Publication date: April 20, 2017
    Applicants: MERCK PATENT GMBH, Cancer Research Technology Limited
    Inventors: Kai SCHIEMANN, Frank STIEBER, Michel CALDERINI, Julian BLAGG, Aurelie MALLINGER, Dennis WAALBOER, Christian RINK, Simon Ross CRUMPLER
  • Patent number: 9493444
    Abstract: The invention provides novel substituted azaheterocyclic compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Grant
    Filed: January 10, 2013
    Date of Patent: November 15, 2016
    Assignees: Merck Patent GmbH, Cancer Research Technology Limited
    Inventors: Kai Schiemann, Frank Stieber, Christina Esdar
  • Publication number: 20160308129
    Abstract: The present invention relates to compounds of the formula (1), which are suitable for use in electronic devices, in particular in organic electroluminescent devices.
    Type: Application
    Filed: November 18, 2014
    Publication date: October 20, 2016
    Applicant: Merck Patent GmbH
    Inventors: PHILIPP STOESSEL, Irina MARTYNOVA, Elvira MONTENEGRO, Teresa MUJICA-FERNAUD, Frank VOGES, Jonas V. KROEBER, Frank STIEBER
  • Publication number: 20160301005
    Abstract: The present invention relates to certain fluorenes, to the use of the compounds in an electronic device, and to an electronic device comprising at least one of these compounds. Furthermore, the present invention relates to a process for the preparation of the compounds and to a formulation and composition comprising one or more of the compounds.
    Type: Application
    Filed: November 26, 2014
    Publication date: October 13, 2016
    Inventors: JOCHEN PFISTER, Frank STIEBER, Elvira MONTENEGRO, Teresa MUJICA-FERNAUD, Frank VOGES
  • Patent number: 9403799
    Abstract: Compounds selected from the group according to claim 1 are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment of tumors.
    Type: Grant
    Filed: January 22, 2015
    Date of Patent: August 2, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Oliver Schadt, Dieter Dorsch, Frank Stieber, Andree Blaukat